Evidence map›Paper›PMID 32768311›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2020

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients.

Trudy Havermans, Janne Houben, Francois Vermeulen, Mieke Boon, Marijke Proesmans, Natalie Lorent, Erik de Soir, Robin Vos, Lieven Dupont

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. The impact of elexacaftor-tezacaftor-ivacaftor on cardiometabolic risk factors: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Living with cystic fibrosis during the COVID-19 pandemic: a social connectedness perspective.International journal of qualitative studies on health and well-being · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis (Commentary).Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  16. Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Trudy HavermansClinical Psychologist, University Hospitals Leuven, Leuven, Belgium. Electronic address: trudy.havermans@uzleuven.be.
Janne HoubenClinical Psychologist, University Hospitals Leuven, Leuven, Belgium.
Francois VermeulenPediatric Pulmonologist, University Hospitals Leuven, Leuven, Belgium.
Mieke BoonPediatric Pulmonologist, University Hospitals Leuven, Leuven, Belgium.
Marijke ProesmansPediatric Pulmonologist, University Hospitals Leuven, Leuven, Belgium.
Natalie LorentPulmonologist, University Hospitals Leuven, Leuven, Belgium.
Erik de SoirClinical Psychologist, Royal Higher Institute for Defence, Department of Scientific and Technological Research, Brussels, Belgium.
Robin VosPulmonologist, University Hospitals Leuven, Leuven, Belgium.
Lieven DupontPulmonologist, University Hospitals Leuven, Leuven, Belgium.
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about the impact of COVID-19 on patients with cystic fibrosis (CF), despite being considered a high-risk group. This study explored the early impact of COVID-19 on the emotional well-being of patients and self-reported changes in their home therapy since the start of the pandemic.

methodsAdult patients with CF, lung-transplanted (LTX) CF patients and parents of children with CF completed an online questionnaire, securely linked to their medical files. The questionnaire covered the emotional impact of the pandemic, changes in CF and LTX treatment, changes in health-protecting behaviours and CF-related concerns, and their perception of their COVID-19 status.

resultsThe response rate was 63% (80 CF, 66 LTX and 73 parents). A wide range of illness severity was included. None of the respondents had contracted COVID-19 and all strictly followed the social distancing rules. There was evident psychological impact, with many reporting increased stress, fear and worry about CF and the future. Changes in treatment were positive, including more physiotherapy for adults and better-quality nebulizing. Changes in routine were reported, such as different treatment timing. Adult patients and parents had cancelled their CF appointments more often since the start of the pandemic.

conclusionsThe initial psychological impact of COVID-19 was evident. The impact on home treatment was reassuringly small. Psychological care is needed for patients suffering prolonged psychological impact, and CF teams need to contextualize the information that patients and parents receive from the media and support them to balance the perceived risk with true risk.

Indexed as

COVID-19Cystic FibrosisHome Care ServicesPsychological DistressAdultBelgiumChildCommunicable Disease ControlFemaleHumansLung TransplantationMaleMental HealthParentsPhysical DistancingRisk AssessmentCOVID-19Cystic fibrosisHome treatmentLung transplantationPsychological impact

Identifiers

PMID32768311
PMCPMC7834420
OpenAlexW3046509408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.